Analytical Data
-
Gene name
LYG1
-
简介
LYG1, a classical secretory protein, belongs to the lysozyme G family. LYG1 inhibits tumor growth by promoting the activation, proliferation, and function of CD4+ T cells. LYG1 also has a hydrolase activity and is involved in the degradation of peptidoglycans from bacterial membranes[1][2]. LYG1 Protein, Human (sf9, His) is the recombinant human-derived LYG1 protein, expressed by Sf9 insect cells , with C-His labeled tag.
- Application
-
Alternative Names
Lysozyme g-like protein 1; LYG1
-
Species
Human
-
Source
Baculovirus
-
Tag
C-His
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q8N1E2
-
Expression Region
S20-F194
-
Protein Length
Full Length of Mature Protein
-
Molecular Weight
22 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
LYG1, also known as Lysozyme G1, is a protein that has garnered increasing attention for its potential applications in biotechnology and medicine. It plays a crucial role in various biological processes, particularly in the innate immune response, where it exhibits antimicrobial properties. The significance of LYG1 lies in its ability to hydrolyze bacterial cell walls, thus contributing to pathogen clearance. Research into LYG1 has expanded in recent years, focusing on its structure, function, and mechanism of action. Scientists have been exploring methods for recombinant expression of LYG1 to produce large quantities of the protein for further studies and potential therapeutic uses. By utilizing recombinant DNA technology, researchers aim to enhance the yield and activity of LYG1, allowing for detailed investigations into its enzyme kinetics and interactions with other biomolecules. Additionally, understanding the molecular basis of LYG1's antimicrobial activity could pave the way for developing new anti-infective agents, especially in the face of rising antibiotic resistance. Overall, the study of LYG1 not only contributes to our understanding of immune defense mechanisms but also opens up opportunities for innovative approaches in drug development and therapeutic interventions against infectious diseases.
